Wixela Inhub vs. AirDuo RespiClick: Comparison
Are Wixela Inhub and AirDuo RespiClick the Same Thing?
Wixela Inhub (fluticasone propionate and salmeterol inhalation powder) and AirDuo RespiClick (fluticasone propionate and salmeterol) inhalation powder both contain a combination of a corticosteroid and a long-acting beta-adrenergic agonist (LABA) used for twice-daily treatment of asthma.
Wixela Inhub is used to treat asthma in patients aged 4 years and older or for maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).
AirDuo RespiClick is used to treat asthma in patients aged 12 years and older.
Side effects of Wixela Inhub and AirDuo RespiClick that are similar include oral thrush (oral candidiasis), cough, and headaches.
Side effects of Wixela Inhub that are different from AirDuo RespiClick include upper respiratory tract infection or inflammation, sore throat, hoarseness, bronchitis, nausea, vomiting, pneumonia, and musculoskeletal pain.
Side effects of AirDuo RespiClick that are different from Wixela Inhub include runny or stuffy nose and back pain.
Both Wixela Inhub and AirDuo RespiClick may interact with antivirals, azole antifungals, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, beta-blockers, and diuretics.
Wixela Inhub may also interact with other medicines containing a LABA, clarithromycin, telithromycin, and nefazodone.
What Are Possible Side Effects of Wixela Inhub?
Common side effects of Wixela Inhub include:
- upper respiratory tract infection or inflammation,
- sore throat,
- hoarseness,
- oral thrush,
- bronchitis,
- cough,
- headaches,
- nausea and vomiting,
- pneumonia,
- viral respiratory infections, and
- musculoskeletal pain
What Are Possible Side Effects of AirDuo RespiClick?
Common side effects of AirDuo RespiClick include:
- runny or stuffy nose,
- Contact
- Location map
- For professionals
